- Henry Schein ( NASDAQ: HSIC ) issued 2023 earnings per share guidance that is well above the consensus estimate.
- The dental products company is projecting non-GAAP diluted EPS of $5.25 to $5.42 ($4.98 consensus). However, this excludes amortization expense of acquired intangible assets.
- The 2023 EPS estimate represents growth -2% to +1% compared with 2022 due to lower sales of personal protective equipment and COVID-19 test kits.
- Henry Schein ( HSIC ) is anticipating sales growth of 1% to 3% over 2022.
- In Q4, the company beat on the top line and barely missed on the bottom .
- Though revenue increased modestly in the quarter compared to Q4 2021, Henry Schein ( HSIC ) was weighed down by $121M in restructuring and integration costs.
- The company ended 2022 with cash and cash reserves of $117M, just $1M less than at the end of 2021.
- Read why Seeking Alpha contributor Zach Bristow recently reiterated his buy rating for Henry Schein ( HSIC ).
For further details see:
Henry Schein issues 2023 EPS guidance that comes in above consensus